14
Oct
Zealand Pharma is at the forefront of developing the next generation of obesity drugs, as stated by its CEO, who highlights rivalry with established treatments such as Wegovy and emerging ones such as Zepbound. This competition highlights the dynamic nature of the pharmaceutical industry's quest to deliver more effective weight management solutions. Obesity represents a critical global health challenge, prompting pharmaceutical companies to invest heavily in research and development. The emergence of innovative drugs like Wegovy and Zepbound demonstrates the industry's commitment to addressing this rampant problem with new treatments. These drugs represent a significant evolution over traditional weight loss…